Milestones to optimize of transjugular intrahepatic portosystemic shunt technique as a method for the treatment of portal hypertension complications.

Publisher: Baishideng Publishing Group Country of Publication: United States NLM ID: 101532469 Publication Model: Print Cited Medium: Print ISSN: 1948-5182 (Print) NLM ISO Abbreviation: World J Hepatol Subsets: PubMed not MEDLINE

Publication: 2014- : Pleasanton, CA : Baishideng Publishing Group
Original Publication: Beijing, China : Baishideng

This editorial describes the milestones to optimize of transjugular intrahepatic portosystemic shunt (TIPS) technique, which have made it one of the main methods for the treatment of portal hypertension complications worldwide. Innovative ideas, subsequent experimental studies and preliminary experience of use in cirrhotic patients contributed to the introduction of TIPS into clinical practice. At the moment, the main achievement in optimize of TIPS technique is progress in the qualitative characteristics of stents. The transition from bare metal stents to extended polytetrafluoroethylene-covered stent grafts made it possible to significantly prevent shunt dysfunction. However, the question of its preferred diameter, which contributes to an optimal reduction of portal pressure without the risk of developing post-TIPS hepatic encephalopathy, remains relevant. Currently, hepatic encephalopathy is one of the most common complications of TIPS, significantly affecting its effectiveness and prognosis. Careful selection of patients based on cognitive indicators, nutritional status, assessment of liver function, etc. , will reduce the incidence of post-TIPS hepatic encephalopathy and improve treatment results. Optimize of TIPS technique has significantly expanded the indications for its use and made it one of the main methods for the treatment of portal hypertension complications. At the same time, there are a number of limitations and unresolved issues that require further randomized controlled trials involving a large cohort of patients.
Competing Interests: Conflict-of-interest statement: Author has no conflict of interest to declare.
(©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.)

AJR Am J Roentgenol. 1985 Oct;145(4):821-5. (PMID: 3876006)
Dig Liver Dis. 2017 Feb;49(2):121-137. (PMID: 27884494)
JHEP Rep. 2021 Mar 03;3(3):100264. (PMID: 34013182)
World J Gastroenterol. 2014 Jan 21;20(3):774-85. (PMID: 24574750)
Micromachines (Basel). 2022 Jan 16;13(1):. (PMID: 35056305)
Hepatology. 2024 Jan 1;79(1):224-250. (PMID: 37390489)
Cardiovasc Intervent Radiol. 2019 Jan;42(1):78-86. (PMID: 30073477)
J Gastroenterol Hepatol. 2010 Nov;25(11):1718-25. (PMID: 21039832)
World J Gastroenterol. 2019 Mar 7;25(9):1088-1099. (PMID: 30862997)
J Vasc Interv Radiol. 2017 Jan;28(1):117-125. (PMID: 27553918)
BMC Gastroenterol. 2023 Nov 20;23(1):403. (PMID: 37986043)
BMC Surg. 2019 Dec 12;19(1):191. (PMID: 31830972)
Radiologe. 1989 Aug;29(8):406-11. (PMID: 2798853)
J Hepatol. 2022 Apr;76(4):959-974. (PMID: 35120736)
Diagn Interv Imaging. 2021 May;102(5):279-285. (PMID: 33303394)
Therap Adv Gastroenterol. 2017 Jan;10(1):32-41. (PMID: 28286557)
J Hepatol. 2021 Jan;74(1):230-234. (PMID: 32987029)
Sci Rep. 2022 Mar 3;12(1):3559. (PMID: 35241785)
Diagn Interv Imaging. 2016 Nov;97(11):1103-1107. (PMID: 27423709)
Eur Radiol. 2023 Apr;33(4):2647-2654. (PMID: 36454260)
Eur Radiol. 2017 May;27(5):1795-1803. (PMID: 27629421)
Radiology. 1969 Apr;92(5):1112-4. (PMID: 5771827)
Cardiovasc Intervent Radiol. 1990 Jun-Jul;13(3):200-7. (PMID: 2121348)
BMC Gastroenterol. 2022 Jul 29;22(1):363. (PMID: 35906529)
Dig Dis Sci. 2021 Nov;66(11):4058-4062. (PMID: 33236314)
PLoS One. 2019 Feb 27;14(2):e0212658. (PMID: 30811467)
Scand J Gastroenterol. 2018 Oct - Nov;53(10-11):1153-1164. (PMID: 30345856)
Cardiovasc Intervent Radiol. 2012 Dec;35(6):1295-300. (PMID: 23070105)
Expert Rev Gastroenterol Hepatol. 2023 Feb;17(2):155-173. (PMID: 36594658)
AJR Am J Roentgenol. 1986 Dec;147(6):1251-4. (PMID: 3490761)
Gastroenterology Res. 2023 Apr;16(2):68-78. (PMID: 37187555)
J Hepatol. 2021 Jul;75 Suppl 1:S14-S26. (PMID: 34039485)
Radiology. 1995 Aug;196(2):341-7. (PMID: 7617843)
Clin Gastroenterol Hepatol. 2018 Jul;16(7):1153-1162.e7. (PMID: 29378312)
J Vasc Interv Radiol. 2004 Mar;15(3):239-48. (PMID: 15028808)
J Clin Med. 2023 Dec 19;13(1):. (PMID: 38202028)
AJR Am J Roentgenol. 1983 Apr;140(4):709-14. (PMID: 6601376)
Semin Intervent Radiol. 2014 Sep;31(3):258-61. (PMID: 25177087)
Diagn Interv Radiol. 2023 Jan 11;29(1):146-154. (PMID: 36960571)
Gut. 2020 Jul;69(7):1173-1192. (PMID: 32114503)
J Hepatol. 2023 Sep;79(3):692-703. (PMID: 37141993)
Am J Surg. 1971 May;121(5):588-92. (PMID: 5105031)
Clin Gastroenterol Hepatol. 2022 Aug;20(8):1636-1662.e36. (PMID: 34274511)
J Clin Exp Hepatol. 2023 Sep-Oct;13(5):794-803. (PMID: 37693277)
Liver Int. 2009 Aug;29(7):1101-9. (PMID: 19386025)
J Belg Soc Radiol. 2022 Jun 29;106(1):62. (PMID: 35854822)
Hepatology. 2021 Jan;73(1):366-413. (PMID: 33219529)
ISRN Hepatol. 2014 Mar 18;2014:762096. (PMID: 27335841)
Diagn Interv Radiol. 2022 May;28(3):239-243. (PMID: 35748206)
Aliment Pharmacol Ther. 2022 May;55(10):1265-1276. (PMID: 35181894)
AJR Am J Roentgenol. 2008 Dec;191(6):1751-7. (PMID: 19020247)
World J Hepatol. 2016 Dec 28;8(36):1602-1609. (PMID: 28083082)
J Clin Med. 2023 Oct 25;12(21):. (PMID: 37959225)
J Chin Med Assoc. 2024 Mar 1;87(3):245-251. (PMID: 38109364)

Keywords: Gastroesophageal variceal bleeding; Liver cirrhosis; Management; Portal hypertension; Prevention; Transjugular intrahepatic portosystemic shunt

Date Created: 20240701 Latest Revision: 20240702

20240702

PMC11212652

10.4254/wjh.v16.i6.891

38948432